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Abstract
Background: The transcriptional regulation of Plasmodium during its complex life cycle requires
sequential activation and/or repression of different genetic programmes. MicroRNAs (miRNAs) are
a highly conserved class of non-coding RNAs that are important in regulating diverse cellular
functions by sequence-specific inhibition of gene expression. What is know about double-stranded
RNA-mediated gene silencing (RNAi) and posttranscriptional gene silencing (PTGS) in Plasmodium
parasites entice us to speculate whether miRNAs can also function in Plasmodium-infected RBCs.
Results:  Of 132 small RNA sequences, no Plasmodium-specific miRNAs have been found.
However, a human miRNA, miR-451, was highly expressed, comprising approximately one third of
the total identified miRNAs. Further analysis of miR-451 expression and malaria infection showed
no association between the accumulation of miR-451 in Plasmodium falciparum-iRBCs, the life cycle
stage of P. falciparum in the erythrocyte, or of P. berghei in mice. Moreover, treatment with an
antisense oligonucleotide to miR-451 had no significant effect on the growth of the erythrocytic-
stage P. falciparum.
Methods: Short RNAs from a mixed-stage of P. falciparum-iRBC were separated in a denaturing
polyacrylamide gel and cloned into T vectors to create a cDNA library. Individual clones were then
sequenced and further analysed by bioinformatics prediction to discover probable miRNAs in P.
falciparum-iRBC. The association between miR-451 expression and the parasite were analysed by
Northern blotting and antisense oligonucleotide (ASO) of miR-451.
Conclusion: These results contribute to eliminate the probability of miRNAs in P. falciparum. The
absence of miRNA in P. falciparum could be correlated with absence of argonaute/dicer genes. In
addition, the miR-451 accumulation in Plasmodium-infected RBCs is independent of parasite
infection. Its accumulation might be only the residual of erythroid differentiation or a component
to maintain the normal function of mature RBCs.
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Background
MicroRNAs (miRNAs), a newly discovered class of endog-
enous ~21 nucleotide regulatory non-coding small RNAs,
post-transcriptionally regulated gene expression in
eukaryotes by targeted RNA degradation and translational
arrest [1]. Similarly to short interfering RNAs (siRNAs),
miRNAs are produced in the cytoplasm from a precursor,
which contains an imperfectly matched inverted repeat
forming a partial double-stranded region, by the ribonu-
clease, dicer. One strand of the resulting miRNA duplex
intermediate is then recruited by the argonaute nuclease,
an enzyme involved in the silencing mechanism, and
incorporated into the RNA-induced silencing complex
(RISC). The mature single-stranded miRNA guides the tar-
get RISC to bind to the 3' untranslated regions of target
mRNAs based on sequence complementarity, which are
then degraded and/or translationally inhibited. Since the
discovery of the founding members of the miRNA family,
lin-4 and let-7[2,3], hundreds of miRNAs had been identi-
fied in viruses, plants, and animals by molecular cloning
and bioinformatic approaches [4-7].
The malaria parasite Plasmodium falciparum is a eukaryote
with a complex life cycle in two hosts and a unique reper-
toire of proteins expressed at distinct life cycle stages. Its
genome is strikingly A-T rich (80%–90%) [8,9]. The pau-
city of annotated transcription factors and the phased
expression of blood stage transcripts have led to the pro-
posal that post-transcriptional gene silencing is an impor-
tant mechanism in the regulation of gene expression in
Plasmodium [10]. Moreover, the phenomenon of double-
stranded RNA-mediated gene silencing (RNAi) in the Plas-
modium parasite had been reported in several studies [11-
15]. In addition, ~21 nucleotide siRNAs were found in
other protozoa such as Tetrahymena thermophila,
Trypanoma brucei, and Entamoeba histolytica[16,17]. In
Entamoeba histolytica, the presence of siRNAs was investi-
gated, and seventeen putative miRNA candidates were
identified by bioinformatics methods [18]. However, bio-
informatics analysis of the P. falciparum genome showed
that the genes encoding dicer and argonaute, which are
crucial components in the RNAi pathway and play a key
role in miRNA biogenesis and functional pathways, were
absent [10,19,20].
In this study, a possibility of the miRNAs present in P. fal-
ciparum was investigated. Consistent with a recent report
[21], P. falciparum-specific miRNAs were not found. How-
ever, Short RNAs from infected red blood cells (iRBCs),
including miRNAs that matched human genomic
sequences, particularly showed an abundant human
miRNA in iRBC. The associations between the generation
of these miRNAs and the infection of Plasmodium were
explored.
Methods
Parasites, animals, and reagents
The 3D7 strain of P. falciparum was cultured in vitro using
group O blood according to Trager's method[22]. A vial
containing P. berghei ANKA strain frozen in liquid nitro-
gen was thawed quickly and injected intraperitoneally
with 107 parasitized erythrocyte into KM mice with age of
6~8 weeks. When the parasitaemia in the mice reached
approximately 10%, the blood was harvested for detecting
expression of miR-451. Thin blood smears were prepared
to determine parasitaemia.
Small RNA preparation, cloning and analysis
The cloning and analysis of small RNAs was performed as
described previously[5]. Briefly, total RNAs were isolated
using Trizol reagent (Invitrogen) from a mixed-stage of
the parasite including ring stage, trophazoite and schiz-
oint when the parasitemia reached approximately 10%,
and short RNAs 18 to 25 nucleotides in length were puri-
fied by 15% PAGE with 8 M urea. This approach is
expected to clone all cellular miRNAs, including miRNAs
from erythrocytes and Plasmodium, as well as any frag-
ments of cellular mRNAs or noncoding RNAs that fall into
this size range. After ligating 3' and 5' adapters (Takara,
Dalian, China) to the small RNAs, the resultant miRNAs
could be amplified by standard RT-PCR. The cDNAs then
were concatenated, cloned and sequenced. The annota-
tion was based on information from GenBank [23], a
database of P. falciparum genome [24], a dataset of human
tRNA sequences[25], and a database of miRNAs[26]. The
genomic regions containing candidate sequences with
~70 bp flanking sequences were used to predict secondary
structures using RNA-fold software such as Mfold[27].
Northern blot analysis
Total RNAs were subjected to electrophoresis on a 15%
polyacrylamide gel under denaturing conditions, and the
separated molecules were transferred electrophoretically
to a Hybond-N nylon membrane (Pall-Gelman, USA).
The membranes were hybridized with a biotin-labeled oli-
gonucleotide probe (Invitrogen, Shanghai, China) corre-
sponding to mature miRNA sequences. After incubation
with streptavidin-horseradish peroxidase conjugate and
an enhanced light-based chemiluminescent substrate
detection system (Pierce), signals were detected by cover-
ing the membrane with plastic wrap and exposing to X-ray
film.
Synthesis and administration of miR-451 antisense oligos 
(ASO)
The unconjugated locked nucleic acids (LNA)-modified
oligonucleotides (Sangon, Shanghai, China) were synthe-
sized as the substitution of every third nucleotide position
by LNA. The anti-miR-451 LNA oligonucleotide 5'-aaAct-
CagTaaTggTaaCggTtt-3' (uppercase: LNA; lowercase:Malaria Journal 2008, 7:47 http://www.malariajournal.com/content/7/1/47
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DNA) was complementary to the mature miR-451
sequence. The substance was formulated in RPMI 1640
medium containing 25 mM HEPES, 24 mM NaHCO3,
and 15% (vol/vol) heat-inactivated rabbit serum to final
concentration of 10, 100, 500 and 1000 nM for P. falci-
parum  cultivation. Highly-synchronized P. falciparum-
infected erythrocytes were adjusted to the original culture
with approximately 2% hematocrit and 0.5% parasitae-
mia. After incubating with different concentrations of the
miR-451 ASO for 72 hr, thin blood smears were prepared
to determine parasitaemia of each sample by counting the
number of parasites in 2,000 erythrocytes.
Results
Cloning of short RNAs from P. falciparum-infected RBCs
Total 132 short RNAs 18–26 nucleotides in length were
obtained through cloning of cDNAs from P. falciparum-
infected RBCs. Of the 132 short RNAs, 54 (40.91%) were
rRNAs and tRNAs from human blood and Plasmodium, 18
(13.64%) were degraded fragments of human blood and
Plasmodium mRNA, 36 (27.27%) were human miRNAs,
and 24 (18.18%) did not match the human nor Plasmo-
dium genome. Consistent with recent reports[21], no Plas-
modium-specific miRNAs sequences were
identified(Figure 1). The human miR-451 accumulated at
a very high level, comprising almost 1/3 of the identified
miRNAs isolated from P. falciparum-iRBCs (Table 1).
Northern blot analysis confirmed the abundance of miR-
451 in Plasmodium-infected RBCs.
The association between miR-451 expression level and the 
development of erythrocyte-stage P. falciparum
The specificity of miR-451 expression was firstly investi-
gated. To eliminate the possibility that the accumulated
miR-451 in P. falciparum-iRBCs were derived from con-
tamination by human white blood cells (WBCs), the tran-
scription of miR-451 in parasite-iRBC and human WBCs
was analysed by Northern blot. The result showed that
miR-451 was transcribed at a very high level in P. falci-
parum-iRBCs, whereas no miR-451 transcripts were
observed in human WBCs (Figure 2A).
The malaria parasite in infected erythrocytes has several
developmental stages, including the early ring tropho-
zoite, late trophozoite, and schizont. To investigate the
association between the expression level of miR-451 and
parasite development, the transcription of miR-451 at dif-
ferent development stages of synchronized P. falciparum-
infected RBCs was assayed by Northern blot. Compared to
equivalent amounts of total RNA (2 µg) per lane, there
were no significant difference in accumulated miR-451
transcription levels from rings to pigmented trophozoite
stages. Moreover, when total RNA from equivalent num-
bers of erythrocytes was loaded, there was also no signifi-
cant difference among them, although the transcription
level of miR-451 seemed slightly lower in the next gener-
ation (cultivated after 72 h) (Figure 2B).
To further analyse the potential functions of miR-451 in
the development of erythrocyte-stage parasites, the Plas-
modium-infected RBCs were synchronized and cultured in
RPMI-1640 medium containing an ASO of miR-451 (San-
gon, Shanghai, China)[22]. Different concentrations of
the miR-451 ASO were added to the cultures and parasi-
taemias were determined. No interfering effect of the ASO
Distribution of cloned short RNAs from P. falciparum-iRBC Figure 1
Distribution of cloned short RNAs from P. falci-
parum-iRBC. One-hundred thirty-two short RNAs 18 to 26 
nucleotides in length were isolated from P. falciparum-iRBCs 
and grouped according to sequence annotation (see Materi-
als and Methods for details). Those with more than three 
mismatches to human or Plasmodium sequences were classi-
fied as ???.
Table 1: Frequencies of known miRNAs identified from P. 
falciparum-iRBCs
miRNAs Number of clones Percentage(%)
hsa-let-7a 12 . 7 8
hsa-let-7b 7 19.44
hsa-let-7f 12 . 7 8
hsa-mir-16 6 16.67
hsa-mir-91 25 . 5 6
hsa-mir-92 12 . 7 8
hsa-mir-106 12 . 7 8
hsa-mir-142 25 . 5 6
hsa-mir-144 25 . 5 6
hsa-mir-451 14 38.89
Total 36 100Malaria Journal 2008, 7:47 http://www.malariajournal.com/content/7/1/47
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of miR-451 on the parasite growth was observed com-
pared to the untreated group.
Expression of miR-451 in P. berghei-infected mouse 
erythrocytes
In addition to Homo sapiens, miR-451 is also expressed in
other species, such as Mus musculus, Rattus norvegicus,
Danio rerio, Xenopus tropicalis, Gallus gallus, and Monodel-
phis domestica [26]. In this study, the expression of miR-
451 in the blood of KM mice was confirmed by Northern
blot analysis (Figure 3). The investigation whether the
expression of miR-451 could be influenced by Plasmodium
infection in vivo was performed by using the P. berghei
(ANKA strain) mice model. The results showed that miR-
451 expression, when comparing equivalent amounts of
RNA, decreased slightly from lower to higher parasitaemia
and became undetectable at 86% parasitaemia (Figure
3A). However, if the total RNAs loaded were adjusted
based on the number of blood cells, the difference in miR-
451 transcript level disappeared (Figure 3B). This indi-
cated that the weak signal of the miR-451 transcript in
samples with higher parasitaemia was due to dilution of
parasite RNAs.
Discussion
Eukaryotes with a complex life cycle may be particularly
likely to express miRNAs, as they could regulate their gene
expression at different stages of their life cycle or affect
host cell factors that increase the likelihood of maintain-
ing long-term infection in the host. miRNAs from the host
cell may also participate in the regulation of parasite gene
expression even if Plasmodium  cannot produce its own
miRNAs. Therefore, miRNAs present in Plasmodium-
infected RBCs were examined by using a short RNA clon-
ing approach. Similar to the results of Rathjen et al [21],
no any Plasmodium-specific miRNAs was detected, further
eliminating the probability of miRNAs in P. falciparum. If
any regulatory RNAs exist in P. falciparum, they will be dis-
tinct from miRNAs. However, some known human miR-
NAs did isolate. Notably, the miRNA miR-451
accumulated to a very high level in infected RBCs, com-
prising more than one third of the cloned miRNAs. So the
Analysis of miR-451 expression in the blood of P. berghei- infected KM mice at different parasitaemias Figure 3
Analysis of miR-451 expression in the blood of P. 
berghei-infected KM mice at different parasitaemias. 
Female KM mice (6–8 weeks old) were infected with the 
blood stages of P. berghei (ANKA strain) by intraperitoneal 
injection of 105 infected erythrocytes. The course of infec-
tion was monitored by examination of Giemsa-stained blood 
films. (A) Total RNAs from the whole blood of uninfected 
and infected mice with different parasitaemias were analysed 
by Northern blotting. Lane 1, whole healthy blood; lane 2, 
0.5% parasitaemia; lane 3, 2% parasitaemia; lane 4, 12% para-
sitaemia; lane 5, 28% parasitaemia; lane 6, 43% parasitaemia; 
lane 7, 60% parasitaemia; lane 8, 86% parasitaemia. (B) Total 
RNAs from equivalent numbers of blood cells (107) with dif-
ferent parasitaemias were analysed by Northern blotting. 
Lane 1, whole healthy blood; lane 2, 43% parasitaemia; lane 3, 
60% parasitaemia.
Detection of expression of miR-451 by Northern blot Figure 2
Detection of expression of miR-451 by Northern blot. 
(A) Analysis of miR-451 expression in human WBCs 
and P. falciprum-iRBCs. Total RNA (2 µg) from WBCs 
and P. falciprum-iRBCs was separated by denaturing PAGE 
and blotted to a nylon membrane. Biotin-labeled miR-451 
was used as a hybridization probe. Lane 1, infected RBC; 
Lane 2, isolated WBCs. (B) Analysis of miR-451 expres-
sion in different erythrocytic-stage P. falciparum-
iRBCs. Total RNA (2 µg) from known numbers of cells 
were prepared at 24 h intervals from a single tightly synchro-
nized culture. Parasite stage was determined by thin blood 
smears. Lane 1, healthy human RBCs; lane 2, 0-h culture after 
tight synchronization (ring-stage iRBCs); lane 3, 24-h culture 
(late trophozoite-stage iRBCs); lane 4, 48-h culture (sch-
izont-stage iRBCs); lane 5, 72-h culture (new reproductive 
cycle of P. falciparum); lane 6, purified P. falciparum; lane 7, 
purified P. falciparum treated with RNase H to remove resid-
ual RNA contamination; lane 8, 72-h culture of P. falciparum-
iRBCs loaded with equivalent numbers of erythrocytes as 
lane 2.Malaria Journal 2008, 7:47 http://www.malariajournal.com/content/7/1/47
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relationship between malaria infection and the expression
of miR-451 were further explored.
The data presented here showed that accumulation of
miR-451 in RBCs is unrelated to the life cycle of P. falci-
parum in the erythrocytic stage and parasitaemia in vivo,
which suggested that the miR-451 expressed at high levels
in RBCs is independent of parasite infection. The weaker
expression of miR-451 in higher parasitaemia, as detected
by Northern blotting, is due to dilution of parasite RNAs,
because this difference was abolished after adjusting the
total RNAs loaded based on the number of blood cells. In
addition, an ASO against miR-451, which normally inhib-
its miRNA activity [28-30], had no observable effects on
the growth of P. falciparum. Several potential explanations
need to be addressed in future studies: (1) the ASO failed
to diffuse into the RBCs, presumably due to their integra-
tion in the cell membrane of RBCs and the presence of
nuclease in medium; (2) the accumulation of miR-451 to
a very high level in RBCs abolished the inhibitory func-
tion of the ASO, even the ASOs that could enter the cells;
(3) the lower affinity of the locked nucleic acid (LNA/
DNA) miR-451 ASO might influence the formation of sta-
ble complexes with the blocking oligonucleotide [31].
Further investigations are required to delineate the rela-
tionship between P. falciparum infection and human
miRNA accumulation in RBCs.
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